We serve Chemical Name:Methyl 4-methoxy-1H-indole-3-carboxylate CAS:161532-19-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 4-methoxy-1H-indole-3-carboxylate
CAS.NO:161532-19-0
Synonyms:Methyl 4-methoxy-1H-indole-3-carboxylate
Molecular Formula:C11H11NO3
Molecular Weight:205.21000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:370.1ºC at 760 mmHg
Density:1.253g/cm3
Index of Refraction:1.612
PSA:51.32000
Exact Mass:205.07400
LogP:1.96310
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 4-methoxy-1H-indole-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-methoxy-1H-indole-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 4-methoxy-1H-indole-3-carboxylate Use and application,Methyl 4-methoxy-1H-indole-3-carboxylate technical grade,usp/ep/jp grade.
Related News: If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. Methyl 4-methoxy-1H-indole-3-carboxylate manufacturer The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. Methyl 4-methoxy-1H-indole-3-carboxylate supplier The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. Methyl 4-methoxy-1H-indole-3-carboxylate vendor The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. Methyl 4-methoxy-1H-indole-3-carboxylate factory If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes.